Skip to main navigation

Press Releases

Press Releases

Year

May 30, 2023

Personalis Announces Two Abstracts Accepted for Presentation at ASCO 2023

May 16, 2023

Personalis, National Cancer Center Hospital East, and Ono Collaborate to Better Predict Immunotherapy Response for Rectal Cancer

May 03, 2023

Personalis Reports First Quarter 2023 Financial Results

May 02, 2023

Personalis, ABRCC, and Criterium Announce Major Prospective Clinical Trial for Residual and Recurrent Disease Detection in Triple Negative Breast Cancer

Apr 19, 2023

Personalis to Announce First Quarter 2023 Financial Results

Apr 05, 2023

Personalis to Participate at the 22nd Annual Needham Virtual Healthcare Conference

Apr 05, 2023

Personalis Joins Top UK Cancer Research Organizations to Evaluate Earlier Cancer Recurrence Detection Through Groundbreaking Study

Mar 22, 2023

Personalis Announces Four Abstracts Accepted for Presentation at AACR Annual Meeting 2023

Mar 07, 2023

Personalis Selected for Clinical Research After Successful Evaluation of Whole Genome-Based Molecular Residual Disease Assay

Mar 02, 2023

Personalis Appoints Christopher Hall as Chief Executive Officer

Pagination

Current page 1
Page 2
Next page
Last page

Displaying 1 - 10 of 15

Print Page

RSS Feeds

Email Alerts

Contact IR

Corporate Website